Anti-EGFR antibodies and antibody drug conjugates

The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

Saved in:
Bibliographic Details
Main Authors HSIEH, CHUNG-MING, MEULBROEK, JONATHAN A, REILLY, EDWARD B, PEREZ, JENNIFER, BUCHANAN, FRITZ G, PHILLIPS, ANDREW C, BENATUIL, LORENZO
Format Patent
LanguageChinese
English
Published 01.08.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
Bibliography:Application Number: TW202211137074